HPV Self-sampling cost effectiveness model

The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV. The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a cl...